Extracellular vesicle-based formulation of doxorubicin: drug loading optimization, characterization, and cytotoxicity evaluation in tumor spheroids

References

• Abrahams C, Woudberg NJ, Lecour S. 2022. Anthracycline-induced cardiotoxicity: Targeting high-density lipoproteins to limit the damage? Lipids Health Dis. 21(1):85. doi: 10.1186/s12944-022-01694-y.
   Google Scholar
• Aldughaim MS, Muthana M, Alsaffar F, Barker MD. 2020. Specific targeting of PEGylated liposomal doxorubicin (Doxil(®)) to tumour cells using a novel TIMP3 peptide. Molecules. 26(1). doi: 10.3390/molecules26010100.
   Google Scholar
• Aloss K, Hamar P. 2023. Recent preclinical and clinical progress in liposomal doxorubicin. Pharmaceutics. 15(3). doi: 10.3390/pharmaceutics15030893.
   Google Scholar
• Baddela VS, Nayan V, Rani P, Onteru SK, Singh D. 2016. Physicochemical biomolecular insights into buffalo milk-derived nanovesicles. Appl Biochem Biotechnol. 178(3):544-557. doi: 10.1007/s12010-015-1893-7.
   Google Scholar
• Balyasnikova IV, Zannikou M, Wang G, Li Y, Duffy JT, Levine RN, Seblani M, Gaikwad H, Simberg D. 2022. Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors. J Control Release. 349:413-424. doi: 10.1016/j.jconrel.2022.07.008.
   Google Scholar
• Bruno S, Collino F, Iavello A, Camussi G. 2014. Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth. Front Immunol. 5:382. doi: 10.3389/fimmu.2014.00382.
   Google Scholar
• Campea MA, Lofts A, Xu F, Yeganeh M, Kostashuk M, Hoare T. 2023. Disulfide-cross-linked nanogel-based nanoassemblies for chemotherapeutic drug delivery. ACS Appl Mater Interfaces. 15(21):25324-25338. doi: 10.1021/acsami.3c02575.
   Google Scholar
• Chen NN, Zhou KF, Miao Z, Chen YX, Cui JX, Su SW. 2024. Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1. Mol Cell Probes. 76:101964. doi: 10.1016/j.mcp.2024.101964.
   Google Scholar
• Chen X, Feng J, Chen W, Shao S, Chen L, Wan H. 2022. Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer. Cell Commun Signal. 20(1):141. doi: 10.1186/s12964-022-00945-w.
   Google Scholar
• Duan M, Zhou D, Ke J, Chen Y, Wu W, Li Y, Ren J, Wang L, Zhang Z, Wang C. 2024. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency. Colloids Surf B Biointerfaces. 238:113892. doi: 10.1016/j.colsurfb.2024.113892.
   Google Scholar
• Farhat W, Yeung V, Kahale F, Parekh M, Cortinas J, Chen L, Ross AE, Ciolino JB. 2022. Doxorubicin-loaded extracellular vesicles enhance tumor cell death in retinoblastoma. Bioengineering (Basel). 9(11). doi: 10.3390/bioengineering9110671.
   Google Scholar
• Fazel M, Daeihamed M, Osouli M, Almasi A, Haeri A, Dadashzadeh S. 2018. Preparation, in-vitro characterization and pharmacokinetic evaluation of Brij decorated doxorubicin liposomes as a potential nanocarrier for cancer therapy. Iran J Pharm Res. 17(Suppl2):33-43. doi.
   Google Scholar
• Fraguas-Sánchez AI, Martín-Sabroso C, Fernández-Carballido A, Torres-Suárez AI. 2019. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemother Pharmacol. 84(4):689-706. doi: 10.1007/s00280-019-03910-6.
   Google Scholar
• Gallegos-Martínez S, Choy Buentello D, Pérez-Álvarez KA, Lara-Mayorga IM, Aceves-Colin AE, Zhang YS, Trujillo-de Santiago G, Álvarez MM. 2024. A 3D-printed tumor-on-chip: user-friendly platform for the culture of breast cancer spheroids and the evaluation of anti-cancer drugs. Biofabrication. doi: 10.1088/1758-5090/ad5765.
   Google Scholar
• Gentile P. 2022. Breast cancer therapy: The potential role of mesenchymal stem cells in translational biomedical research. Biomedicines. 10(5). doi: 10.3390/biomedicines10051179.
   Google Scholar
• Holub AR, Huo A, Patel K, Thakore V, Chhibber P, Erogbogbo F. 2020. Assessing advantages and drawbacks of rapidly generated ultra-large 3D breast cancer spheroids: Studies with chemotherapeutics and nanoparticles. Int J Mol Sci. 21(12). doi: 10.3390/ijms21124413.
   Google Scholar
• Iacopetta D, Ceramella J, Baldino N, Sinicropi MS, Catalano A. 2023. Targeting breast cancer: An overlook on current strategies. Int J Mol Sci. 24(4). doi: 10.3390/ijms24043643.
   Google Scholar
• Ichim TE, O’Heeron P, Kesari S. 2018. Fibroblasts as a practical alternative to mesenchymal stem cells. Journal of Translational Medicine. 16(1):212. doi: 10.1186/s12967-018-1536-1.
   Google Scholar
• Jain A, Jain SK. 2016. In vitro release kinetics model fitting of liposomes: An insight. Chemistry and Physics of Lipids. 201:28-40. doi: 10.1016/j.chemphyslip.2016.10.005.
   Google Scholar
• Lee C, Kumar S, Park J, Choi Y, Clarissa EM, Cho Y-K. 2024. Tonicity-induced cargo loading into extracellular vesicles. Lab on a Chip. 24(7):2069-2079. doi: 10.1039/D3LC00830D.
   Google Scholar
• Lennaárd AJ, Mamand DR, Wiklander RJ, El Andaloussi S, Wiklander OPB. 2021. Optimised electroporation for loading of extracellular vesicles with doxorubicin. Pharmaceutics. 14(1). doi: 10.3390/pharmaceutics14010038.
   Google Scholar
• Li X-R, Cheng X-H, Zhang G-N, Wang X-X, Huang J-M. 2022. Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer. Journal of Ovarian Research. 15(1):96. doi: 10.1186/s13048-022-01029-6.
   Google Scholar
• Mardpour S, Ghanian MH, Sadeghi-Abandansari H, Mardpour S, Nazari A, Shekari F, Baharvand H. 2019. Hydrogel-mediated sustained systemic delivery of mesenchymal stem cell-derived extracellular vesicles improves hepatic regeneration in chronic liver failure. ACS Appl Mater Interfaces. 11(41):37421-37433. doi: 10.1021/acsami.9b10126.
   Google Scholar
• Mehryab F, Rabbani S, Shahhosseini S, Shekari F, Fatahi Y, Baharvand H, Haeri A. 2020. Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges. Acta Biomater. 113:42-62. doi: 10.1016/j.actbio.2020.06.036.
   Google Scholar
• Mehryab F, Rabbani S, Shekari F, Nazari A, Goshtasbi N, Haeri A. 2024. Sirolimus-loaded exosomes as a promising vascular delivery system for the prevention of post-angioplasty restenosis. Drug Deliv Transl Res. 14(1):158-176. doi: 10.1007/s13346-023-01390-z.
   Google Scholar
• Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A. 2023. Exosomes as cutting-edge therapeutics in various biomedical applications: An update on engineering, delivery, and preclinical studies. Biochimie. 213:139-167. doi: 10.1016/j.biochi.2023.05.010.
   Google Scholar
• Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X et al. 2018. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 3(8). doi: 10.1172/jci.insight.99263.
   Google Scholar
• Mukhopadhya A, Tsiapalis D, McNamee N, Talbot B, O'Driscoll L. 2023. Doxorubicin loading into milk and mesenchymal stem cells' extracellular vesicles as drug delivery vehicles. Pharmaceutics. 15(3). doi: 10.3390/pharmaceutics15030718.
   Google Scholar
• Obireddy SR, Lai WF. 2022. ROS-generating amine-functionalized magnetic nanoparticles coupled with carboxymethyl chitosan for pH-responsive release of doxorubicin. Int J Nanomedicine. 17:589-601. doi: 10.2147/ijn.S338897.
   Google Scholar
• Shekari F, Nazari A, Assar Kashani S, Hajizadeh-Saffar E, Lim R, Baharvand H. 2021. Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: a systematic review. Cytotherapy. 23(4):277-284. doi: 10.1016/j.jcyt.2020.12.009.
   Google Scholar
• Singh A, Lofts A, Krishnan R, Campea M, Chen L, Wan Y, Hoare T. 2024. The effect of comb length on the in vitro and in vivo properties of self-assembled poly(oligoethylene glycol methacrylate)-based block copolymer nanoparticles. Nanoscale Adv. 6(9):2487-2498. doi: 10.1039/d3na01156a.
   Google Scholar
• Siva D, Abinaya S, Rajesh D, Archunan G, Padmanabhan P, Gulyás B, Achiraman S. 2022. Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid. Nanomaterials (Basel). 12(3). doi: 10.3390/nano12030502.
   Google Scholar
• Soekmadji C, Li B, Huang Y, Wang H, An T, Liu C, Pan W, Chen J, Cheung L, Falcon-Perez JM et al. 2020. The future of extracellular vesicles as theranostics - an ISEV meeting report. J Extracell Vesicles. 9(1):1809766. doi: 10.1080/20013078.2020.1809766.
   Google Scholar
• Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, Balant S, Rahman MH. 2022. Nanomedicine-based delivery strategies for breast cancer treatment and management. Int J Mol Sci. 23(5). doi: 10.3390/ijms23052856.
   Google Scholar
• Théry C, Amigorena S, Raposo G, Clayton A. 2006. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. Chapter 3:Unit 3.22. doi: 10.1002/0471143030.cb0322s30.
   Google Scholar
• Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK et al. 2018. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles. 7(1):1535750. doi: 10.1080/20013078.2018.1535750.
   Google Scholar
• Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, Tang L, Ma X, Zhang Y, Wang Y. 2021. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials. 273:120784. doi: 10.1016/j.biomaterials.2021.120784.
   Google Scholar
• Wang S, Qiao C, Kong X, Yang J, Guo F, Chen J, Wang W, Zhang B, Xiu H, He Y et al. 2024. Adhesion between EVs and tumor cells facilitated EV-encapsulated doxorubicin delivery via ICAM1. Pharmacol Res. 205:107244. doi: 10.1016/j.phrs.2024.107244.
   Google Scholar
• Wang X, Zhao Y, Yan M, Liang X, Zhao N, Lu T. 2024. iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors. Eur J Pharm Sci. 195:106725. doi: 10.1016/j.ejps.2024.106725.
   Google Scholar
• Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y, Wu C, Lin J, Zhong G. 2022. Mesenchymal stem cell derived exosomes as nanodrug carrier of doxorubicin for targeted osteosarcoma therapy via SDF1-CXCR4 axis. Int J Nanomedicine. 17:3483-3495. doi: 10.2147/ijn.S372851.
   Google Scholar
• Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C, Liu Z, Zhong G, Lin J. 2019. A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro. Int J Nanomedicine. 14:8603-8610. doi: 10.2147/ijn.S218988.
   Google Scholar
• Wu J. 2021. The enhanced permeability and retention (EPR) effect: The significance of the concept and methods to enhance its application. J Pers Med. 11(8). doi: 10.3390/jpm11080771.
   Google Scholar
• Xiao R, Ye J, Li X, Wang X. 2023. Dual size/charge-switchable and multi-responsive gelatin-based nanocluster for targeted anti-tumor therapy. Int J Biol Macromol. 238:124032. doi: 10.1016/j.ijbiomac.2023.124032.
   Google Scholar
• Yakavets I, Ayachit M, Kheiri S, Chen Z, Rakhshani F, McWhirter S, Young EWK, Walker GC, Kumacheva E. 2024. A microfluidic platform for evaluating the internalization of liposome drug carriers in tumor spheroids. ACS Appl Mater Interfaces. 16(8):9690-9701. doi: 10.1021/acsami.3c16330.
   Google Scholar
• Yamashita S, Imanishi A, Ueki S, Okamoto S, Kimura S, Kiriyama A. 2024. Pharmacokinetic-pharmacodynamic analysis of pH-responsive doxorubicin-releasing micelles with anticancer activity. Mol Pharm. doi: 10.1021/acs.molpharmaceut.3c01171.
   Google Scholar
• Yang B, Song BP, Shankar S, Guller A, Deng W. 2021. Recent advances in liposome formulations for breast cancer therapeutics. Cell Mol Life Sci. 78(13):5225-5243. doi: 10.1007/s00018-021-03850-6.
   Google Scholar
• Zaer M, Moeinzadeh A, Abolhassani H, Rostami N, Tavakkoli Yaraki M, Seyedi SA, Nabipoorashrafi SA, Bashiri Z, Moeinabadi-Bidgoli K, Moradbeygi F et al. 2023. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach. Int J Biol Macromol. 253(Pt 2):126808. doi: 10.1016/j.ijbiomac.2023.126808.
   Google Scholar
• Zlotogorski-Hurvitz A, Dekel BZ, Malonek D, Yahalom R, Vered M. 2019. FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer. J Cancer Res Clin Oncol. 145(3):685-694. doi: 10.1007/s00432-018-02827-6.
   Google Scholar